| --- | --- | |-------------|-------| | | | | | | | | | | | | | Reimagining | | Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries ("LifeStance") and the industry in which LifeStance operates, including statements regarding: full-year and fourth quarter guidance ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ...

Core Viewpoint - LifeStance Health Group (LFST) reported a quarterly loss of $0.02 per share, outperforming the Zacks Consensus Estimate of a loss of $0.07, and showing improvement from a loss of $0.17 per share a year ago [1] Financial Performance - The company achieved revenues of $312.72 million for the quarter ended September 2024, exceeding the Zacks Consensus Estimate by 3.72% and up from $262.9 million in the same quarter last year [2] - Over the last four quarters, LifeStance Health has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance - LifeStance Health shares have declined approximately 8.9% since the beginning of the year, contrasting with the S&P 500's gain of 24.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.06 on revenues of $308.84 million, and -$0.25 on revenues of $1.22 billion for the current fiscal year [7] - The estimate revisions trend for LifeStance Health is mixed, which may change following the recent earnings report [6] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which LifeStance Health belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024. (All results compared to prior-year comparative period, unless otherwise noted)Q3 2024 Highlights and FY 2024 Outlook Revenue of $312.7 million increased 19% compared to revenue of $262.9 millionClinician base increased 13% to 7,269 clinicians, a sequential ne ...

Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Third Quarter 2024 Results SCOTTSDALE, Ariz. – November 7, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q3 2024 Hi ...

TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended August 31, 2024 ("Q3 2024") compared to the same period last year ("Q3 2023"). All financial figures are in Canadian dollars unless otherwise indicated. Third Quarter ...

SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationa ...

Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare SCOTTSDALE, Ariz., Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure. Nearly four out of five (79%) respondents said the upcoming U.S. presidential election has caused th ...

TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the "Closing") of CannMart Inc. ("CannMart"), a B2B wholesale distribution business facilitating recreational cannabis sales ...

Core Viewpoint - LifeStance Health Group (LFST) shows potential for further upside, with a mean price target of $7.93 indicating a 26.7% increase from its current price of $6.26 [1] Price Target Analysis - The mean estimate consists of seven short-term price targets with a standard deviation of $1.43, indicating variability among analysts [2] - The lowest estimate is $6, suggesting a 4.2% decline, while the highest estimate is $10, indicating a potential surge of 59.7% [2] - A low standard deviation signifies a high degree of agreement among analysts regarding the stock's price movement [7] Earnings Estimates - Analysts have shown increasing optimism about LFST's earnings prospects, with a strong consensus in revising EPS estimates higher [9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 3.9%, with two estimates moving higher and no negative revisions [10] - LFST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11]